RU2056836C1 - Agent for burn and purulent wound treatment - Google Patents
Agent for burn and purulent wound treatment Download PDFInfo
- Publication number
- RU2056836C1 RU2056836C1 SU5063926A RU2056836C1 RU 2056836 C1 RU2056836 C1 RU 2056836C1 SU 5063926 A SU5063926 A SU 5063926A RU 2056836 C1 RU2056836 C1 RU 2056836C1
- Authority
- RU
- Russia
- Prior art keywords
- burn
- ointment
- burns
- wound
- wound treatment
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Изобретение относится к медицине, в частности к лечению ожогов и гнойных ран. The invention relates to medicine, in particular to the treatment of burns and purulent wounds.
Известная мазь Линетол, предназначенная для лечения ожогов, недостаточно эффективна и противопоказана при гнойных ранах. Мазь Винилин, применяющаяся для лечения ран и ожогов, недостаточно эффективна. The well-known Linetol ointment, intended for the treatment of burns, is not effective enough and is contraindicated in purulent wounds. Vinylin ointment, used to treat wounds and burns, is not effective enough.
Цель изобретения повышение эффективности заживания ожогов и гнойных ран. The purpose of the invention is improving the healing of burns and purulent wounds.
Сущность изобретения заключается в применении известной технической смазки ЦИАТИМ-221 в качестве мази для лечения ожогов и гнойных ран. Согласно ГОСТ 9433-60 ЦИАТИМ-221 высокотемпературная водостойкая смазка, мягкая мазь белого или светло-серого цвета, продукт загустения кремнийорганической жидкости 132-24 (ПЭС-С-1) (84%) комплексным кальциевым мылом (16%) стеариновой и уксусных кислот. Работоспособна при температуре от 60оС до 150оС. Предназначена для смазывания узлов трения и сопряженных поверхностей металл-металл и металл-резина, работающих в агрессивных средах.The essence of the invention lies in the use of the well-known technical lubricant TsIATIM-221 as an ointment for the treatment of burns and purulent wounds. According to GOST 9433-60 TsIATIM-221, a high-temperature waterproof grease, a soft ointment of white or light gray color, a thickening product of organosilicon liquid 132-24 (PES-S-1) (84%) with complex calcium soap (16%) of stearic and acetic acids . The temperature range from 60 C to 150 C. Suitable for lubricating friction units of the mating surfaces and metal to metal and metal-rubber operating in corrosive environments.
П р и м е р 1. Больная К. поступила в больницу 24.05.93 с ожогом левой голени кипящей водой, ожог II степени около 4% кожи. Рана была обработана. Сразу после промывки фурациллином на рану была нанесена мазь ЦИАТИМ-221. Отечность и выделения из раны исчезли через сутки. Мазь на рану наносилась повторно через каждые сутки. Полная эпителизация раны наступила через 10 дней. PRI me R 1. Patient K. was admitted to the hospital 05.24.93 with a burn of the left lower leg with boiling water, II degree burn of about 4% of the skin. The wound was healed. Immediately after washing with furatsillin, ointment TsIATIM-221 was applied to the wound. Swelling and discharge from the wound disappeared after a day. Ointment was applied repeatedly to the wound every day. Complete epithelialization of the wound occurred after 10 days.
П р и м е р 2. Больной К. поступил в больницу 07.06.93 с ожогами кипящей водой I и II степени (ожоги I степени до 10% кожи, ожоги II степени около 4% ). После нанесения смазки ЦИАТИМ-221 на раны без повязок на 2-й день исчезла отечность вокруг ожоговых ран, на 3-й день на местах ожогов I-й степени кожа приобрела обычную окраску и эластичность, на местах ожогов II степени кожа почти полностью эпителизовалась на 7-й день, на 12-й день практически не было отличий поврежденной и здоровой кожи. 20.06.93 выписан на работу. PRI me R 2. Patient K. was admitted to the hospital 07.06.93 with burns of boiling water I and II degree (burns I degree up to 10% of the skin, burns II degree about 4%). After applying TsIATIM-221 lubricant to wounds without dressings, on the 2nd day the swelling around the burn wounds disappeared, on the 3rd day, on the sites of burns of the 1st degree, the skin acquired normal color and elasticity, on the sites of burns of the 2nd degree, the skin almost completely epithelized on 7th day, on the 12th day there was practically no difference between damaged and healthy skin. 06/20/93 discharged to work.
П р и м е р 3. Больная М. обратилась в больницу по поводу инфицированной рубленной раны правой стопы. Рана 10 х 3 х 1,5 см была покрыта слизистогнойным отделением. После промывания раны 3%-ной перекисью водорода на рану была нанесена мазь ЦИАТИМ-221. На следующий день рана очистилась, уменьшилась отечность краев раны, на 7-й день рана зажила вторичным натяжением. Мазь наносилась на рану через день. При применении смазки ЦИАТИМ-221 в качестве мази при лечении больных токсических явлений препарата местного или общего действия не наблюдалось. PRI me R 3. Patient M. went to the hospital about an infected chopped wound of the right foot. The wound 10 x 3 x 1.5 cm was covered with a mucous membrane. After washing the wound with 3% hydrogen peroxide, ointment TsIATIM-221 was applied to the wound. The next day, the wound cleansed, swelling of the edges of the wound decreased, on the 7th day the wound healed by secondary intention. The ointment was applied to the wound every other day. When using TsIATIM-221 lubricant as an ointment in the treatment of patients with toxic effects of the drug local or general action was not observed.
По заявлению всех больных им приятно применение мази ЦИАТИМ-221. Ни одного ухудшения состояния здоровья или побочных отрицательных проявлений от применения смазки ЦИАТИМ-221 в качестве мази у больных не наблюдалось. According to the statement of all patients, they are pleased with the use of TsIATIM-221 ointment. Not a single deterioration in health status or adverse side effects from the use of TsIATIM-221 lubricant as an ointment was observed in patients.
Таким образом использование смазки ЦИАТИМ-221 в качестве мази для лечения ожогов и гнойных ран ускоряет заживание ожогов, в том числе и гнойных ожоговых ран, во многих случаях исключает необходимость пересадки кожи. Она может применяться в домашних условиях, в ожоговых и хирургических отделениях больниц. Использование смазки ЦИАТИМ-221 в качестве мази позволит также сэкономить средства по разработке и совершенствованию мазей для лечения ожогов и гнойных ран, уменьшить расход перевязочного материала. Thus, the use of TsIATIM-221 lubricant as an ointment for the treatment of burns and purulent wounds accelerates the healing of burns, including purulent burn wounds, and in many cases eliminates the need for skin grafts. It can be used at home, in the burn and surgical departments of hospitals. The use of TsIATIM-221 lubricant as an ointment will also save money on the development and improvement of ointments for the treatment of burns and purulent wounds, and reduce the consumption of dressing material.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU5063926 RU2056836C1 (en) | 1992-10-05 | 1992-10-05 | Agent for burn and purulent wound treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU5063926 RU2056836C1 (en) | 1992-10-05 | 1992-10-05 | Agent for burn and purulent wound treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2056836C1 true RU2056836C1 (en) | 1996-03-27 |
Family
ID=21614106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU5063926 RU2056836C1 (en) | 1992-10-05 | 1992-10-05 | Agent for burn and purulent wound treatment |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2056836C1 (en) |
-
1992
- 1992-10-05 RU SU5063926 patent/RU2056836C1/en active
Non-Patent Citations (1)
| Title |
|---|
| Авторское свидетельство СССР N 173882, кл. A 61K 9/06, 1953. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6136341A (en) | Collagen containing tissue adhesive | |
| Fairclough et al. | The prevention of wound contamination by skin organisms by the pre-operative application of an iodophor impregnated plastic adhesive drape | |
| Hermans | Clinical experience with glycerol-preserved donor skin treatment in partial thickness burns | |
| Abdel-Sayed et al. | Implications of chlorhexidine use in burn units for wound healing | |
| Bunyan | Treatment of burns and wounds by the envelope method | |
| Nahlieli et al. | Povidone-iodine related burns | |
| Yadav et al. | Topical phenytoin in the treatment of split-thickness skin autograft donor sites: a comparative study with polyurethane membrane drape and conventional dressing | |
| RU2056836C1 (en) | Agent for burn and purulent wound treatment | |
| DE2945420C2 (en) | ||
| Meleney et al. | The Combined Use of Zinc Peroxide and Sulfanilamide in the Treatment of Chronic, Undermining, Burrowing Ulcers Due to the Micro-Aerophilic Hemolytic Streptococcus | |
| Anderson Jr | THE PROBLEM OF WOUND HEALING THE EFFECT OF LOCAL ANTISEPTIC AGENTS ON INFECTED WOUNDS | |
| RU2722719C1 (en) | Method of treating wounds and trophic ulcers | |
| Van Den Hoogenband | Treatment of leg ulcers with split-thickness skin grafts | |
| Narat | Brilliant green: a clinical study of its value as a local antiseptic | |
| RU2165754C2 (en) | Ointment for treatment of suppurative-inflammatory diseases, burns, articulation inflammatory diseases, trophic ulcers and sluggish wounds, method of its preparing and method of treatment | |
| Tiglis et al. | Hydrotherapy in burn care: Pros, cons and suggestions | |
| Mitura et al. | A change of traditional method of treatment of partial thickness burn with hydrofibre dressings | |
| Scanlon et al. | To use or not to use? The debate on the use of antiseptics in wound care | |
| Golden et al. | " Wringer arm" reevaluated: a survey of current surgical management of upper extremity compression injuries. | |
| DE59504374D1 (en) | Use of deoxyspergualin for the manufacture of a medicament for the treatment of inflammatory hyperreactive diseases | |
| Sawyer et al. | New approaches in the therapy of the peripheral vascular ulcer | |
| Platts et al. | Survival after high-tension electrical burns complicated by acute tubular necrosis | |
| Abali et al. | Our Experience on Topical Usage of Acetic Acid in Pediatric Major Burns | |
| Curtis et al. | New technique for local treatment of burns | |
| Mulder | Synthetic Membranes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REG | Reference to a code of a succession state |
Ref country code: RU Ref legal event code: MM4A Effective date: 20091006 |